Form D · Biotechnology

Vascular Pharmaceuticals, Inc.

Chapel Hill, NC · CIK 0001557160

Offering snapshot reported Jan 6, 2016 · SEC filing

Reported sold
$3M
Offering amount: $3M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 23, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 6, 2016Initial$3,000,000No comparison6SEC filing
Feb 20, 2015Amendment$15,121,488$2,000,001vs Jan 21, 20156SEC filing
Jan 21, 2015Amendment$13,121,487$4,113,154vs Nov 19, 20134SEC filing
Nov 19, 2013Amendment$9,008,333$3,000,004vs Sep 24, 20123SEC filing
Aug 23, 2013Initial$1,000,000No comparison3SEC filing
Sep 24, 2012Initial$6,008,329No comparison3SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-254667

Source: Form D, filed Jan 6, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Clemmons Director
Vaughn Kailian Director
Richard Kent Director
Bonnie Layman Executive
Benjamin Rovinski Director
Richard Shea Director, Executive
Elizabeth Stoner Director
Ken Williams Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
510 Meadowmont Village Circle Suite 283
Chapel Hill, NC, 27517